Biocydex specializes in research of health products and medical engineering to enhance the delivery of drugs into the body. Biocydex is committed to offering new therapeutic medical procedures based on cyclodextrins and development of various innovative products used in the field of ophthalmology, oncology, infectious diseases, organ transplantation and in the nutraceutical field. Biocydex was founded on a portfolio of patents from laboratories CEA and CNRS. Since its inception, Biocydex expanded its intellectual property by filing nine patents, including five in partnership, to protect its research results. Biocydex develops six products, including four drugs incorporating its innovative technologies. The products use the proprietary technologies Vectipharm, Solvamax or Protéosol that improve solubility, stability, bioaccessibility and bioavailability.